Activatable fluorescent probes for imaging and diagnosis of rheumatoid arthritis

Mil Med Res. 2023 Jul 14;10(1):31. doi: 10.1186/s40779-023-00467-7.

Abstract

Rheumatoid arthritis (RA) is a systemic autoimmune disease that is primarily manifested as synovitis and polyarticular opacity and typically leads to serious joint damage and irreversible disability, thus adversely affecting locomotion ability and life quality. Consequently, good prognosis heavily relies on the early diagnosis and effective therapeutic monitoring of RA. Activatable fluorescent probes play vital roles in the detection and imaging of biomarkers for disease diagnosis and in vivo imaging. Herein, we review the fluorescent probes developed for the detection and imaging of RA biomarkers, namely reactive oxygen/nitrogen species (hypochlorous acid, peroxynitrite, hydroxyl radical, nitroxyl), pH, and cysteine, and address the related challenges and prospects to inspire the design of novel fluorescent probes and the improvement of their performance in RA studies.

Keywords: Biomarker; Diagnosis; Fluorescent probe; Imaging; Rheumatoid arthritis.

Publication types

  • Review

MeSH terms

  • Arthritis, Rheumatoid* / diagnostic imaging
  • Arthritis, Rheumatoid* / drug therapy
  • Biomarkers
  • Fluorescent Dyes / therapeutic use
  • Humans
  • Reactive Nitrogen Species / therapeutic use
  • Reactive Oxygen Species
  • Synovitis* / diagnosis

Substances

  • Fluorescent Dyes
  • Biomarkers
  • Reactive Nitrogen Species
  • Reactive Oxygen Species